PAXIL CR
GLAXOSMITHKLINE INC
Quick answers
Is there a shortage of PAXIL CR in Canada?
No. There is no current shortage of PAXIL CR 25MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Why Psychiatric Medications Keep Going Into Shortage in Canada
Why antidepressants and antipsychotics like buspirone, quetiapine, escitalopram, venlafaxine, and paroxetine show up in Canadian shortage reports so often, and what to do if yours is affected.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
APO-PAROXETINE
APOTEX INC
PRO-PAROXETINE
PRO DOC LIMITEE
RATIO-PAROXETINE
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
SANDOZ PAROXETINE TABLETS
SANDOZ CANADA INCORPORATED
PAXIL CR
GLAXOSMITHKLINE INC
PAROXETINE
COBALT PHARMACEUTICALS COMPANY
DIN
02248504
Strength
25MG
Dosage Form
Tablet (Extended-Release)
Route
Oral
Active Ingredient
PAROXETINE (PAROXETINE HYDROCHLORIDE)
See all PAROXETINE (PAROXETINE HYDROCHLORIDE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from GLAXOSMITHKLINE INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02245127
DIN 02245126
DIN 02240835
DIN 02240836
DIN 02240837
1MG · DIN 02237820
2.5MG · DIN 02237821
DIN 02418401
120MCG · DIN 02540207
100MCG · DIN 02446561
200MCG · DIN 02446588
27.5MCG · DIN 02298589